Sodium Bicarbonate.

Carnosine's imidazole ring buffers hydrogen ions within the muscle cell and bicarbonate buffers the extracellular space. Raising extracellular buffering speeds hydrogen ion efflux, which is the step intracellular buffering cannot perform.

Phosphocreatine resynthesis by creatine kinase is sensitive to intracellular pH, so a less acidic cell recovers its phosphocreatine faster. Bicarbonate supports pH from outside while creatine raises the substrate pool inside.

Betaine hydrochloride is taken to lower gastric pH and bicarbonate neutralises gastric acid, so each cancels the other's intended effect. Co-dosing them in the same serving makes little sense chemically.

Pepsin needs a strongly acidic stomach to be activated from pepsinogen and to hold its active shape, and it loses activity as pH rises. Bicarbonate raises gastric pH, so it works against the enzyme it is dosed beside.

Gastric proteases work in acid while pancreatic enzymes work near neutral pH, so raising stomach pH shifts which part of a blend is active and where. The interaction is one of timing and location rather than of the enzymes being inactivated outright.

Ferrous iron stays soluble and absorbable in an acidic stomach and precipitates as ferric hydroxide as pH rises. Bicarbonate raises gastric pH, so it lowers the fraction of an iron salt that reaches the duodenal transporter.

Non-heme iron needs gastric acid to stay in the soluble ferrous state before duodenal uptake. Neutralising that acid reduces how much iron is available to absorb from the same dose.

Calcium carbonate needs gastric acid to dissolve and release calcium ions, so it absorbs poorly when pH is raised. Bicarbonate consumes that same acid, and both also contribute to the total alkali load.

Magnesium oxide is poorly soluble and depends on gastric acid to convert it to absorbable magnesium ions. Raising gastric pH with bicarbonate lowers the yield from an already low-solubility salt.

Inorganic zinc salts dissolve in gastric acid before uptake in the small intestine, so a less acidic stomach lowers the ionised fraction. Chelated zinc forms are less affected because they do not rely on acid to dissociate.

Enteric coatings are designed to stay intact in acid and dissolve near neutral pH, so raising gastric pH can release the contents in the stomach instead of the intestine. Separating an alkalinising dose from an enteric-coated one by a couple of hours preserves the coating's purpose.

Gastric acid is the main barrier that kills ingested organisms before they reach the intestine, which is why probiotics are often taken with food or in acid-resistant capsules. Buffering stomach acid raises the share that survives transit.

Sodium bicarbonate is a sodium salt, so its sodium counts toward the same total as added salt. The doses add for fluid retention and blood pressure purposes even though the anions differ.

An alkali load shifts potassium into cells and changes renal potassium handling, so blood potassium can fall as pH rises. Formulators consider the two together rather than dosing bicarbonate against an unexamined potassium intake.

An alkaline load lowers urinary calcium loss because acid loading is what drives calcium out of bone buffers and into urine. That makes bicarbonate a calcium-sparing partner on the excretion side rather than the absorption side.

Ascorbic acid degrades faster in neutral and alkaline solution than in acid, and it reacts with bicarbonate to release carbon dioxide. Combining the two in a liquid dose shortens the vitamin's stability window.

Ingested citrate is oxidised in the TCA cycle and consumes hydrogen ions, which raises circulating bicarbonate without delivering carbon dioxide to the stomach. Taking both raises the same blood buffer and the same sodium load twice over. Combining them is duplication of one endpoint, which is worth stating plainly.

Caffeine works through adenosine receptor antagonism and central drive, while bicarbonate works on extracellular hydrogen ion handling. Because the mechanisms do not overlap, the pairing is conventional in pre-exercise protocols. Both also independently carry gastrointestinal considerations, so the combined stomach load is larger than either alone.

Dietary nitrate is reduced to nitrite and then nitric oxide, affecting blood flow and mitochondrial efficiency, while bicarbonate acts on acid-base handling. The two do not compete for the same mechanism. Note that nitrate reduction depends on oral bacteria and on a low-pH step, so the timing of an alkalising agent is a real formulation question here rather than a theoretical one.

A standard ergogenic dose delivers a sodium load comparable to several grams of table salt. Anyone already taking an electrolyte product is stacking two sodium sources. The total sodium intake, not the bicarbonate, is what should be counted here.

Electrolyte blends and sodium bicarbonate both deliver sodium and both raise luminal osmolality when taken concentrated. Osmotic water draw into the gut is the mechanism behind much of the discomfort reported with bicarbonate protocols. Splitting the doses and diluting them is the ordinary handling.

Magnesium salts draw water into the intestinal lumen osmotically and bicarbonate does the same while also generating carbon dioxide on contact with stomach acid. Taken together the gastrointestinal load adds. A systematic review of bicarbonate protocols catalogued those symptoms and how loading strategy changes them.

Dietary vitamin B12 is bound to food protein and is freed by acid-pepsin digestion before it can bind haptocorrin and then intrinsic factor. Neutralising gastric acid interferes with that first step, which is why sustained acid suppression is associated with lower B12 status. Crystalline B12 in a supplement is not protein-bound and does not depend on that step.

Pancreatic lipase is irreversibly inactivated below about pH 4 and works optimally near neutral, which is why the pancreas secretes bicarbonate into the duodenum alongside the enzymes. Enteric coating exists precisely to carry enzymes past gastric acid. This is why acid neutralisation and pancreatic enzyme activity are linked in normal physiology.

Supplemental lipase carries the same pH sensitivity as the pancreatic enzyme it copies, losing activity in an acidic environment and regaining it as duodenal bicarbonate raises pH. The relationship is a property of the enzyme, not an effect of a supplement pairing. It explains why lipase products are formulated with acid protection.

Salicylate is a weak acid that is reabsorbed in the renal tubule in its uncharged form. Raising urine pH keeps more of it ionised and trapped in the tubular fluid, so more is excreted. This is textbook ion trapping and it applies to any weak acid handled the same way.

Trivalent cations are more soluble at low pH and tend to form less soluble hydroxides as pH rises. Neutralising gastric acid works against that solubilisation step. Spacing mineral doses away from an alkalising agent is the usual approach.

Manganese salts need gastric acid to dissolve before uptake in the proximal small intestine, the same dependency documented for iron and zinc. Raising gastric pH reduces the dissolved fraction available. Dose separation is how formulators handle it.

Thiamine degrades rapidly at alkaline pH, which is why it is formulated as an acid salt such as the hydrochloride or mononitrate. Combining it in solution with a strongly alkalising agent is a stability question rather than an absorption one. In a dry blend the two are physically separate and the issue does not arise.